SENSEX NIFTY
Ranbaxy Laboratories Quarterly Results, Ranbaxy Laboratories Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 30, 17:00
623.75
1.6 (0.26%)
VOLUME 107,802
LIVE
NSE
Oct 30, 17:00
623.30
-0.05 (-0.01%)
VOLUME 1,856,538
Download Annual Report PDF Format 2014 | 2011 | 2010

Quarterly Results of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Sep '14 Jun '14 Mar '14 Dec '13 Sep '13
Net Sales/Income from operations 1,272.69 2,116.98 1,224.59 1,327.64 1,381.84
Other Operating Income 46.23 61.65 27.43 38.93 43.99
Total Income From Operations 1,318.91 2,178.63 1,252.02 1,366.56 1,425.84
EXPENDITURE
Consumption of Raw Materials 335.94 280.73 394.87 432.75 427.49
Purchase of Traded Goods 227.01 184.27 224.77 219.36 184.24
Increase/Decrease in Stocks 101.17 102.74 3.29 -82.70 -70.65
Power & Fuel -- -- -- -- --
Employees Cost 279.67 254.74 226.27 271.91 267.67
Depreciation 60.15 65.65 49.98 45.85 94.41
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 530.80 429.76 440.48 591.29 718.97
P/L Before Other Inc. , Int., Excpt. Items & Tax -215.82 860.74 -87.64 -111.90 -196.28
Other Income 20.02 25.76 636.50 20.60 44.35
P/L Before Int., Excpt. Items & Tax -195.80 886.50 548.86 -91.30 -151.93
Interest 136.82 141.91 110.85 118.39 111.08
P/L Before Exceptional Items & Tax -332.63 744.59 438.02 -209.69 -263.01
Exceptional Items -35.63 19.77 490.41 -186.28 -579.22
P/L Before Tax -368.26 764.36 928.43 -395.96 -842.23
Tax -- 9.24 30.57 -- --
P/L After Tax from Ordinary Activities -368.26 755.12 897.86 -395.96 -842.23
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period -368.26 755.12 897.86 -395.96 -842.23
Equity Share Capital 211.95 211.78 211.66 211.55 211.57
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -8.69 17.83 21.22 -9.36 -19.92
Diluted EPS -8.69 17.80 21.19 -9.36 -19.92
EPS After Extra Ordinary
Basic EPS -8.69 17.83 21.22 -9.36 -19.92
Diluted EPS -8.69 17.80 21.19 -9.36 -19.92
Public Share Holding
No Of Shares (Crores) 14.93 14.49 14.88 14.80 14.28
Share Holding (%) 35.22 34.18 35.11 34.93 33.75
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 26.87 26.87 26.87 26.87 26.87
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 63.37 63.40 63.41 63.41 63.51
Notes
Source : Dion Global Solutions Limited
Quick Links for ranbaxylaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.